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Summary.-A comparison has been made between the carcinogenic activities of
benzo(a)pyrene and the proposed proximate carcinogen, benzo(a)pyrene7,8-dihydro-
diol, in the adult C57BL mouse submandibular salivary gland. In preliminary studies
using a range of doses, the dihydrodiol was slightly less active than the parent
hydrocarbon in this system.
There was a difference in the type of tumour induced by the 2 compounds.
Benzo(a)pyrene induced tumours of the salivary glands at the site of injection,
whereas the dihydrodiol induced malignant lymphosarcomas, particularly of the
thymus, which were often metastatic to other organs.
Possible reasons for the different sites ofaction ofthe2 compounds are discussed.
BENZO(A)PYRENE (B(a)P; Fig. 1, I) is a
widespread environmental contaminant,
and as such as been implicated as a
potential carcinogen in man (Epstein,
1974). The carcinogenic potency of B(a)P
in laboratory animals has been well docu-
mented. Metabolic activation of the poly-
cyclic aromatic hydrocarbon carcinogens
to electrophylic derivatives is thought to
be essential for their toxic, mutagenic
and carcinogenic activities (Miller, 1970;
Gelboin, et al., 1972; Huberman and
Sachs, 1974). Recently, the ultimate
metabolite of B(a)P which binds cova-
lently to DNA and is largely respon-
sible for its muitagenic activity (New-
bold et al., 1977) has been identified
as the 7,8-dihydrodiol-9,10-epoxide (Fig.
1, III) (Sims et al., 1974), which binds
predominantly to the extra-nuclear amino
group ofguanine (Osborne et al., 1q976a, b).
Chromatographically identical hydro-
carbon-DNA adducts have been identified
wNhen B(a)P is painted on to mouse skin
(Grover et al., 1976) or incubated in vitro
with mouse embryo fibroblasts (Baird
et al., 1975) or salivary gland epithelial
cells (Wigley et al., 1976). The immediate
precursor of the diolepoxide is the 7,8-
dihydrodiol (Fig. 1, II) which requires
epoxidation at the 9,10 double bond
before it can bind covalently to DNA.
This has therefore been proposed as the
proximate carcinogen.
Since the dihydrodiol is a more stable
compound than the diol-epoxide, it has
been used in studies comparing its carcino-
genic activity with that of the parent
hydrocarbon, B(a)P (Slaga et al., 1976;
Levin et al., 1977a; Kapitulnik et al.,
1977). In experiments using the mouse-
skin initiation-promotion system, chronic
application to mouse skin, or i.p. injection
into newborn mice, the 7,8-dihydrodiol
derivative was found to be about as
active as, or, in newborns, more active
carcinogenically than B(a)P. Recently, the
diol-epoxide has also been found to be an
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FiG. 1. Structural formulae. I, Benzo(a)-
pyrene, and its metabolic derivatives, II,
B(a)P 7,8-dihydrodiol and III, B(a)P 7,8-
(lihydrodiol-9,1O-epoxide (anti).
effective tumour initiator on mouse skin,
if dissolved in tetrahydrofuran (Slaga et
al., 1977).
When the present study was begun,
many ofthese reports hadnotyetappeared
in the literature. In addition, it was
considered important that compounds
were tested in as many different systems as
possible to assess their carcinogenic poten-
tial in a wide range of tissues. Previously,
dimethylbenz(a)anthracene (DMBA) had
been shown to induce submandibular
salivary gland tumours readily, particular-
ly squamous carcinomas, when it was
injected directly into the glands of adult
mice (Wigley and Carbonell, 1976). This
study confirmed earlier reports that the
epithelium of this gland was particularly
susceptible to hydrocarbon carcinogenesis
(Rusch et al., 1942). Since in vitro trans-
formation studies with salivary gland cells
have recently used B(a)P rather than
DMBA (Wigley, unpublished) because its
metabolic fate is more clearly understood,
it was of interest to determine the carci-
nogenicity of the parent hydrocarbon and
the proposed proximate carcinogen in the
salivary gland in vivo. The results of
preliminary dose-response studies are re-
ported here.
MATERIALS AND METHODS
Benzo(a)pyrene was purchased from Sigma
Chemical Co., Kingston-upon-Thames. The
7,8-dihydrodiol of B(a)P was a gift from Dr
R. G. Harvey (Ben AMay Laboratory, Uni-
versity of Chicago). Anaesthetized, 12-wieek-
old, C57BL male mice w-ere injected intra-
glandularly with the doses of each compound
specified in Tables I and II. This dose was
given as 0 05 ml of an emulsion in water-
soluble KY jelly (Johnson and Johnson Ltd,
Slough, Bucks). A more detailed description
of the injection technique is given elsewhere
(Wigley and Carbonell, 1976). A control
group of mice received carrier emulsion only.
Each experimental group consisted of 10
mice, which were checked regularly during
the course of the experiment (1 year) for
the presence of tumours at the injection
site and any indications, such as respiratory
distress, of tumours elsewhere. Tumours and
any other abnormal tissues were fixed at
necropsy for histopathological examination.
RESULTS
The major finding in this study was that
although, as expected, B(a)P induced
salivary-gland tumours at the site of
injection, its derivative, the 7,8-dihydro-
diol, induced malignant lymphosarcomas
at distant sites, particularly the thymus
gland. Many oftheselymphosarcomas were
metastatic to one or more additional sites
such as lung, liver and kidney, whereas the
B(a)P-induced tumours did not meta-
stasize.
There were a few exceptions to this
general pattern, shown in Tables I and II,
where the tumour yields are subdivided
into tumour types histologically and
related to the dose of each compound
658TUMOURS INDUCED BY B(a)P AND B(a)P 7,8-DIHYDRODIOL
TABLE I. Primary Tumour Yields in Mice Injected with Various Doses of B(a)P
Lymphosar-
Dose B(a)P Tumour Rhabdomyo- coma
(mg/mouse) (o)* Fibrosarcoma Carcinoma sarcoma Thymoma (all other sites)
0-1 40 4 0 0 0 0
0-5 90 6 it 1 0 it
2-0 56 4 0 0 0 it
* Basedl on number alive at time of appearance of first tumour.
t Fresent in adldition to a fibrosarcoma (not listed separately).
+ Poun(d at autopsy at the end of the experiment (387 days).
TABLE II. Primary Tumour Yields in Mice Injected with Various Doses of B(a)P
7,8 Dihydrodiol
Ttomour
20
20
50
30
Fibrosarcoma
0
0
0
1t
Carcinoma
0
0
0
0
Rhabdomyo-
sarcoma
0
0
0
1
Lymphosar-
coma
Thymoma (all other sites)
1 1
0 2t
4 1
1 0
* Base(d on iiumber alive at time of appearance of first tumour.
+ Foun(d at autopsy at the end of the experiment (387 days).
injected. B(a)P induced 2 lymphosar-
comas. One in the 0 5 mg-dose group was
a large tumour of a mesenteric lymph node
found at necropsy at the end of the
experiment. Another, smaller, tumour
occurred in the highest-dose group, and
was invading normal submandibular saliv-
ary tissue. There was a salivary-gland
fibrosarcoma in this animal, which was
killed after 284 days for this reason. The
7,8-dihydrodiol induced 1 small fibro-
sarcoma at the site of injection which was
found in the highest-dose group at the end
of the experiment. Both compounds
induced one rhabdomyosarcoma near the
injection site after periods of 129 (B(a)P)
and 179 days. The identity of these
tumours was confirmed by staining sec-
tions with Wiegert's iron haematoxylin to
demonstrate striated muscle filaments in
tumour cells.
Fig. 2 shows the incidence times of
tumours induced by the optimal dose of
each compound (0.5 mg in each case).
From these curves it appears that the
parent hydrocarbon is more active as a
complete carcinogen than the 7,8-dihydro-
diol. The highest dose of both compounds
induced fewer tumours than the optimal
0.5 mg/mouse. The total tumour yield and
incidence times of mice receiving 2-0 mg
100
80
'a)
0
E
0-O
60
40
20
0 . 300 400
Latent period (dys)
Fie. 2. Incidence with time of tumours
inducedl by optimal doses (0-5 mg/mouse)
of B(a)P and B(a)P 7,8-dihydrodiol -
B(a)P; 0 B(a)P 7,8-dihydrodiol.
B(a)P were almost identical to those shown
for 0-5 mg 7,8-dihydrodiol in Fig. 1 (i.e.
there was lower activity than for 0 5 mg
B(a)P).
DISCUSSION
The 7,8-dihydrodiol of B(a)P, believed
to be the proximate carcinogenic meta-
bolite responsible for the initiating activity
of B(a)P, is shown to be a good carcinogen
in this test system. It appears to be rather
less active than the parent hydrocarbon,
Dose B(a)P-
7,8 diol
(mg/mouse)
0-1
0-25
0 5
1-0
a I I
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but possible explanations for this will be
discussed later. However, the tumours
induced by each compound were different.
With I or 2 exceptions, B(a)P induiced
salivary-glanld tumours at the site of
injection, whereas the dihvdr-odiol indtuced
malignant lymphosarcomas of the thymus
(thymomas) or of regional Iymph nodes.
This observation is consistent with the
findings of Kapitulnik et al. (1977) in new
born mice injected i.p.
The difference betweeni the 2 com-
pounds may be partly dtte to their
relative water solubilities. B(a)P is highly
lipid-soluible and would tend to stay at the
site of injeetion, whereas the more water-
soluble dihydrodiol may be dispersed and
able to act on more sensitive target tissues.
The thvmus and other lymphatic tissues
are known to be sensitive to radiation
(Kaplan, 1967) and chemical careino-
genesis (Igel et al., 1969) buit the role of
viruses in the genesis of lymphosarcomas
is unclear. A murine leukaemia virus is
activated in target tissuies after irradia-
tion, but there is doubt about whether the
virus is a caausative factor, at least in
chemical systems (Frei et al., 1973).
Tumours of the lymphatic tissues are a
major cause of death in ageing C57BL
mice, but rarely occur spontaneously in
animals under 16 months (Rowlatt et al.,
1976). The dihydrodiol induced 1 sarcoma
at the site of injection in the highest-dose
group. This indicates that salivary-gland
cells are not completely refractory to
carcinogenesis by this compouind. Fewer
carcinomas compared to sarcomas were
induced by B(a)P in this study than were
found after IDMBA injection (Wigley and
Carbonell, 1976) or in a recent study using
2 mg B(a)P in a larger group of C57BL
Icrf at mice (WVigley, unpublished). B(a)P
was shown, however, to be a good carcino-
gen in the salivary-gland system, although
the average latent period of tumour
development is rather longer than pre-
viously found for DMBA.
Since only small numbers of animals
were used in each dosage group in this
series of experiments, conclusive state-
inenlts calnnot be madle about relative
carcinogenicities of B(a)P ancd its 7,8-
dihydrodiol derivative in this test system.
r'hese experiments were desigined to estab-
lish appropriate doses of each compotund
to be used in subse(quient sttudies, but
results obtained so far are consistent with
conclusions reached by other authors that
the 7,8-dihydrodiol may be a proximate
carcinogen. One observation in particuilar
should be considered. Levin et al. (1.977b)
found a marked difference in carcinog,enic
activity betweeni optically pure + and-
enantiomers of the 7 y8-dihydrodiol. The
synthetic compound used here is a racemic
mixture of both isomers. Increasing the
dose of the dihydrodiol did not, however,
increase the final tumour yield. Instead,
in both the dihydrodiol and B(a)P top-
dose groups the yield was (lecreased. The
reason for this is not known, but if the
observation wvas confirmed with larger
groups of animals it would imply that
increased toxic effects had redtuced the
effective target-cell population.
A consideration of the toxic effects of a
compound, and the resultant stimulation
of regenerative cell division, may provide
an additional explanation for the 2
different sites of action of B(a)P anid its
dihydrodiol derivative. The metabolite
may be less toxic and therefore less able to
stimulate regeneration in the salivary
gland than B(a)P, where additional meta-
bolites, such as phenols, may be toxic but
relatively non-carcinogenic. This regenera-
tion process is thought to be essential to
salivary-gland carcinogenesis (Wigley aind
Carbonell, 1976) since the mitotic rate in
the gland is normally very low. Alitosis can
be stimulated in rodent salivary glands by
isoprenaline. Parkin and Neale (1 976)
found that N-nitro-N-nitrosourea only
induced salivary-gland tumours in rats
after pretreatment with isoprenaline. This
drug, may therefore be effective in increas-
ing the susceptibility of the mouse sub-
mandibular gland to dihydrodiol carcino-
genesis. Because of the higher water
solubility of the dihydrodiol, this com-
pound is able, however, to exert its effects
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on lymphatic tissues at distant sites. The
thymus, for instance, may be more sus-
ceptible to toxicity, and is known to have
high regeneration potential. This hyper-
plasia is also thought to be a necessary
step in the development of thymic
lymphomas (Frei and Maitra, 1974). These
factors may be partially eliminated when
the two compounds are compared as
initiating agents in the two-stage system
oftumorigenesis in mouse skin.
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